Are you Dr. Golubic?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3113 Bellevue Ave
Cincinnati, OH 45219Phone+1 513-475-8730Fax+1 513-475-8033
Summary
- Dr. Mladen Golubic, MD is a board certified internist in Cincinnati, Ohio. He is currently licensed to practice medicine in Ohio. He is affiliated with University of Cincinnati Medical Center.
Education & Training
- Huron HospitalResidency, Internal Medicine, 2006 - 2009
- University of Zagreb Faculty of MedicineClass of 1983
Certifications & Licensure
- OH State Medical License 2006 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Improving Outcomes in Allogeneic Transplantation and Chronic Graft-versus-Host Disease Patients through Lifestyle Medicine: Current Landscape and Future Directions.Aaron T Zhao, Noa G Holtzman, Mladen Golubic, Steven Z Pavletic
Transplantation and Cellular Therapy. 2024-09-01 - Corrigendum to: "Living Well with Chronic Pain": Integrative Pain Management via Shared Medical Appointments.Josie Znidarsic, Kellie N Kirksey, Stephen M. Dombrowski, Anne Tang, Rocio Lopez
Pain Medicine. 2021-09-14 - 12 citations"Living Well with Chronic Pain": Integrative Pain Management via Shared Medical Appointments.Josie Znidarsic, Kellie N Kirksey, Stephen M. Dombrowski, Anne Tang, Rocio Lopez
Pain Medicine. 2021-02-04
Press Mentions
- Are You Overwhelmed by Kindness?September 4th, 2021
- 5 Ways to Achieve a Healthy Balance in LifeFebruary 20th, 2019
- Stimulate Your Vagus Nerve for Better Mental HealthApril 28th, 2017
- Join now to see all
Grant Support
- 5-Lipoxygenase Inhibition As An Adjuvant Glioma TherapyNational Cancer Institute2004